Nattokinase (Subtilisin NAT)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Nattokinase (Subtilisin NAT).

Nattokinase is a potent fibrinolytic serine protease derived from Bacillus subtilis var. natto that directly degrades fibrin and plasminogen activator inhibitor-1 to enhance cardiovascular hemodynamics and reduce thrombotic risk.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

102198147

Molecular Weight

316.4 g/mol

XLogP3 (Lipophilicity)

3.6

IUPAC Name

N-benzoyl-N-benzylpyridine-2-carboxamide

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Vitamin K2 (MK-7) for [Synergistic regulation of arterial calcification and cardiovascular health]
Coenzyme Q10 for [Complementary support of endothelial function and blood pressure management]

Biological Formulation Enhancers

Enteric Coating for [Protection against gastric acid-induced denaturation of the enzyme's tertiary structure]
Sodium Caprate for [Enhancement of paracellular permeability to facilitate the intestinal absorption of large enzyme molecules]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Nattokinase (Subtilisin NAT) across standard consumer modalities.

💊 Standard Capsules

Standard dry powder capsules require enteric protection or delayed-release technology to prevent the acidic environment of the stomach from inactivating the enzyme's fibrinolytic activity.

🍬 Gummy & Pectin Formats

The thermal processing and high moisture content required for gummy production pose a significant risk of denaturing the protein and neutralizing its enzymatic potency.

🔬 Thin-Film Oral Strips

The limited surface area and mass capacity of thin-film matrices restrict the delivery of effective clinical dosages, which are typically measured in thousands of Fibrinolytic Units (FU).

For Brand Founders

Formulate with Nattokinase (Subtilisin NAT)

Ready to launch a product featuring Nattokinase (Subtilisin NAT)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Nattokinase (Subtilisin NAT) Bioavailability

Need absolute proof that your Nattokinase (Subtilisin NAT) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Nattokinase (Subtilisin NAT) Degradation Testing

Is your Nattokinase (Subtilisin NAT) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation